In line with our apoptosis data, CP-CML CD34+ cells in the Sub G0 stage increased proportionally to the dose of SC and even further in the combination arms (Fig. 3B-ii). The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.